Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin

BACKGROUND: We compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes. METHODS: The present study was a multicenter, random...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Kim, Jong Ho, Kim, Sang Soo, Baek, Hong Sun, Lee, In Kyu, Chung, Dong Jin, Sohn, Ho Sang, Bae, Hak Yeon, Kim, Mi Kyung, Park, Jeong Hyun, Choi, Young Sik, Kim, Young Il, Hahm, Jong Ryeal, Lee, Chang Won, Jo, Sung Rae, Park, Mi Kyung, Lee, Kwang Jae, Kim, In Joo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929227/
https://ncbi.nlm.nih.gov/pubmed/27098505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2016.40.3.230
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados